Preventable premature mortality
Advances in health sciences and technology make it possible to avoid a significant proportion of early deaths by adopting appropriate preventive and predictive health measures, backed by timely medical care. This phenomenon is known as preventable premature mortality and reflects deaths that could have been avoided through early intervention and quality care.
The World Health Organization (WHO) emphasizes that deaths occurring in people under 75 years of age can often be prevented with early public health interventions or quality medical treatment once conditions are diagnosed, highlighting its importance as a health systems performance indicator.
The Longevytum approach to reducing risk
At Longevytum, our focus is on identifying and addressing the main causes of preventable premature mortality through a comprehensive analytical and imaging program. This includes biochemical, genetic, and molecular biology testing, along with specialized profiling such as oxidative stress, inflammation, hormonal balance, coagulation factors, gut microbiome assessment, and toxic metals evaluations.
We also analyze specific health domains with the goal of detecting early pathologies and guiding personalized preventive strategies:
Cardiovascular evaluation
Cardiovascular diseases are a leading contributor to early mortality. Standard measures like lipid levels or lifestyle data are insufficient to predict risk precisely, as many heart attacks occur in individuals with normal cholesterol.
For this reason, we perform advanced tests such as LDL-P by MRI, LipoA analysis, and fatty acid profiling in erythrocyte membranes, and when appropriate, Genetic BioChips for higher predictive accuracy. Our imaging assessments include Doppler ultrasounds of major arterial networks, coronary calcium scoring, and Coronary Angio-CT, a 3D non-invasive imaging test that visualizes coronary arteries and detects early obstructions with high predictive value.
Oncological evaluation
Cancer prevention also plays a central role in reducing preventable premature mortality. We apply a suite of specialized analytical tests including PSA, CEA, Alpha-Fetoprotein, and tumor markers like CA 19.9, CA 15.3, and CA 125, along with screening tests like Septin-9 and occult blood tests.
In addition, imaging methods such as Low-Dose CT scans for lung cancer screening (especially in smokers or ex-smokers), Body CT scans for comprehensive thoracoabdominal evaluation, and MRI studies for neurological conditions (e.g., gliosis or ischemia) help detect tumor development at the earliest possible stage.
A proactive path forward
By focusing on early detection, advanced diagnostics, and individualized preventive care, it is possible to significantly lower the risk of early death and improve overall health outcomes. Through proactive management of cardiovascular and oncological risks, prevention becomes a core strategy for enabling longer, healthier lives with better quality of life.
Información y conceptos
Se refiere a aquellas muertes de personas menores de 75 años que pueden evitarse interviniendo tempranamente sobre la salud (cambios en la dieta, práctica deportiva…) o con intervención médica.
Conjunto de pruebas diagnósticas dirigidas a valorar el estado de forma del corazón y los vasos sanguíneos
Conjunto de pruebas diagnósticas dirigidas a detectar distintos tipos de cáncer, tanto en fase siliente como activos